This Week’s Column
Past Columns
Column History
Subscribe Now
Author

CENTRAL VIEW for Monday, May 25, 2020

by William Hamilton, Ph.D.

Explained: The war against Hydroxychloraquine

When a threat like the Red Chinese Coronavirus virus comes along, most folks would probably say, "Pray there is some inexpensive, already invented way to ítreatí this virus." Unfortunately, not everyone thinks that way. Later, more about them.

The bad news is that no drug has ever been invented that will "cure" a virus once it springs to life inside the human body. The good news is that viruses outside the body can be killed by sufficiently strong chemicals, by direct sunlight, by UV-C rays, and even by hot, soapy water. Wearing masks, social distancing, and covering sneezes and coughs, impedes their spread.

Recall, the symptoms presented by the Red Chinese Coronavirus and presented by Hypoxia (oxygen starvation) are almost the same. Ergo: something in the Red Chinese Coronavirus destroys the bloodís ability to deliver oxygen to the lungs and other vital organs.

So, unless there is some kind of drug "treatment" available to restore the ability of the "hemes" to deliver oxygen, the human immune system is the bodyís only defense against the virus. Unfortunately, the immune system can overreact and inflame the organs that are needed to fight the virus. Catch 22.

Now, back to those who do not think as most folks: A new virus presents an opportunity for Big Pharma to produce a patented and expensive new drug. Searching for a Red Chinese Coronavirus treatment means government and university research laboratories could receive millions of dollars in grants. So, if you are the CEO of a pharmaceutical company or the director of a government or university laboratory, you are not likely to look with favor upon an inexpensive, generic drug such as Hydroxychloraquine (HCQ), which has been used safely for decades to treat a variety of other diseases.

In fact, thousands of virus victims, both here and abroad, credit HCQ, combined with Zinc Sulfate and, sometimes, Azithromycin (Z-Pak) with saving their lives. Sermo, a global health-care polling company, presented 6,227 physicians in 30 countries with 15 drug options for treatment of the Red Chinese Coronavirus. Out of those 15 options, 37-percent of those surveyed rated HCQ as the "most effective therapy." None of the other 14 drugs rated that highly.

If you are unaware of the Sermo survey, that is because the left-stream media (LSM), which suffers from Trump Derangement Syndrome (TDS), have joined ranks with Big Pharma and Big Research to condemn the use of HCQ as a Red Chinese Coronavirus preventive or treatment.

When two members of the White House staff tested positive for the Red Chinese Coronavirus, President Trump consulted with his personal physician. They decided a course of HCQ and Zinc Sulfate, along with an initial shot of Azithromycin, might prevent President Trump from contracting the Red Chinese Coronavirus. As of this writing, so far, so good.

Recall, hundreds of thousands of GIs in Vietnam and Cambodia took a weekly dose of Chloroquine -- the basis of Hydroxychloraquine -- without serious side effects.

President Trumpís casual mention of HCQ set off the usual LSM/TDS firestorm. But President Trumps comes off as brave enough to take an "experimental" bullet for the rest of us. And the LSM/TDS crowd gets more crow to eat.

©2020. William Hamilton.

William Hamilton is a laureate of the Oklahoma Military Hall of Fame, the Oklahoma Journalism Hall of Fame, the Nebraska Aviation Hall of Fame, the Colorado Aviation Hall of Fame, and the Oklahoma University Army ROTC Wall of Fame. Dr. Hamiltonís latest book: Formula for Failure in Vietnam: The Folly of Limited Warfare can be ordered toll free at: (800) 253-2187 Or, go to Amazon.com.

©1999-2020. American Press Syndicate.

Dr. Hamilton can be contacted at:
P.O. Box 2001
Granby, CO 80446

Email: william@central-view.com

This Week’s Column
Past Columns
Column History
Subscribe Now
Author